Literature DB >> 8798379

The adaptor protein Nck links receptor tyrosine kinases with the serine-threonine kinase Pak1.

M L Galisteo1, J Chernoff, Y C Su, E Y Skolnik, J Schlessinger.   

Abstract

Nck is an adaptor protein composed of a single SH2 domain and three SH3 domains. Upon growth factor stimulation, Nck is recruited to receptor tyrosine kinases via its SH2 domain, probably initiating one or more signaling cascades. In this report, we show that Nck is bound in living cells to the serine-threonine kinase Pak1. The association between Nck and Pak1 is mediated by the second SH3 domain of Nck and a proline-rich sequence in the amino terminus of Pak1. We also show that Pak1 is recruited by activated epidermal growth factor (EGF) and platelet-derived growth factor receptors. Moreover, Pak1 kinase activity is increased in response to EGF in HeLa cells transfected with human Pak1, and the kinase activity was enhanced when Nck was co-transfected. It is concluded that Nck links receptor tyrosine kinases with Pak1 and is probably involved in targeting and regulation of Pak1 activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798379     DOI: 10.1074/jbc.271.35.20997

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  89 in total

Review 1.  Rho GTPases and their effector proteins.

Authors:  A L Bishop; A Hall
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

Review 2.  Recent developments in lymphocyte activation: linking kinases to downstream signaling events.

Authors:  J L Clements; G A Koretzky
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

3.  Identification of a new Pyk2 target protein with Arf-GAP activity.

Authors:  J Andreev; J P Simon; D D Sabatini; J Kam; G Plowman; P A Randazzo; J Schlessinger
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

4.  NIK is a new Ste20-related kinase that binds NCK and MEKK1 and activates the SAPK/JNK cascade via a conserved regulatory domain.

Authors:  Y C Su; J Han; S Xu; M Cobb; E Y Skolnik
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

5.  GIT1 activates p21-activated kinase through a mechanism independent of p21 binding.

Authors:  Tsui-Han Loo; Yuen-Wai Ng; Louis Lim; Ed Manser
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

6.  Constitutive p21-activated kinase (PAK) activation in breast cancer cells as a result of mislocalization of PAK to focal adhesions.

Authors:  Mary R Stofega; Luraynne C Sanders; Elisabeth M Gardiner; Gary M Bokoch
Journal:  Mol Biol Cell       Date:  2004-03-26       Impact factor: 4.138

Review 7.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

Review 8.  Molecular pathways: targeting p21-activated kinase 1 signaling in cancer--opportunities, challenges, and limitations.

Authors:  Jeyanthy Eswaran; Da-Qiang Li; Anil Shah; Rakesh Kumar
Journal:  Clin Cancer Res       Date:  2012-05-17       Impact factor: 12.531

9.  Requirement of Nck adaptors for actin dynamics and cell migration stimulated by platelet-derived growth factor B.

Authors:  G M Rivera; S Antoku; S Gelkop; N Y Shin; S K Hanks; T Pawson; B J Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

10.  Maturin is a novel protein required for differentiation during primary neurogenesis.

Authors:  Reyna I Martinez-De Luna; Ray Yueh Ku; Yung Lyou; Michael E Zuber
Journal:  Dev Biol       Date:  2013-10-01       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.